Achiko AG (Achiko AG) Accounts Receivable : $0.01 Mil (As of Jun. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Achiko AG Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Achiko AG's accounts receivables for the quarter that ended in Jun. 2022 was $0.01 Mil.

Accounts receivable can be measured by Days Sales Outstanding.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Achiko AG's Net-Net Working Capital per share for the quarter that ended in Jun. 2022 was $-0.07.

Achiko AG Accounts Receivable Historical Data

The historical data trend for Achiko AG's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achiko AG Accounts Receivable Chart

Achiko AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Accounts Receivable

0.55

0.39

0.02

0.03

Achiko AG Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Accounts Receivable	Get a 7-Day Free Trial			0.41	0.02	0.01	0.03	0.01

Achiko AG Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Achiko AG Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Achiko AG's Days Sales Outstanding for the quarter that ended in Jun. 2022 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.005	/	0	*	91
=

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Achiko AG's accounts receivable are only considered to be worth 75% of book value:

Achiko AG's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2022 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(0.054	+	0.75 * 0.005	+	0.5 * 0	-	9.256
-	0	-	0)	/	132.654
=	-0.07

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Achiko AG Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Achiko AG's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Achiko AG (Achiko AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Achiko AG (OTCPK:ACHKF) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tessinerplatz 7, Zurich, CHE, CH-8002

Website

https://www.achiko.com

Achiko AG is developing disruptive diagnostic solutions that put people first. The company product is a rapid, reliable Covid-19 test with a companion app offering a user-friendly digital health passport. Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameX, and companion health apps via its digital mobile health technology division, Teman Sehat. The AptameX DNA aptamer tests can be rapidly chemically synthesized, are cost-effective, and have wide potential across multiple disease diagnostics. Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate, and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.